Canadian cannabis giant Tilray, Inc. (NASDAQ: TLRY) (TSX: TLRY) confirmed Thursday that its medical subsidiary Aphria has launched medical cannabis oral strips in THC and CBD-rich varieties. "Tilray's medical brands, Aphria, Symbios, and Tilray, are relentlessly committed to investing in patient wellness through a portfolio of new innovative product offerings, GMP-certified cultivation, and the earned trust of the medical community," Irwin D. Simon, Tilray's chairman and CEO stated. "The launch of the Aphria-branded medical strips is a compelling proof point in this regard, and, given the growing expansion of medical cannabis across the globe, we believe we are ...Full story available on Benzinga.com